File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/hep.28600
- Scopus: eid_2-s2.0-84987909452
- WOS: WOS:000383285900010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
| Title | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma |
|---|---|
| Authors | |
| Issue Date | 2016 |
| Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ |
| Citation | Hepatology, 2016, v. 64 n. 3, p. 774–784 How to Cite? |
| Description | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma |
| Persistent Identifier | http://hdl.handle.net/10722/231336 |
| ISSN | 2023 Impact Factor: 12.9 2023 SCImago Journal Rankings: 5.011 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cheng, AL | - |
| dc.contributor.author | Thongprasert, S | - |
| dc.contributor.author | Lim, HY | - |
| dc.contributor.author | Sukeepaisarnjaroen, W | - |
| dc.contributor.author | Yang, TS | - |
| dc.contributor.author | Wu, CC | - |
| dc.contributor.author | Chao, Y | - |
| dc.contributor.author | Chan, SL | - |
| dc.contributor.author | Kudo, M | - |
| dc.contributor.author | Ikeda, M | - |
| dc.contributor.author | Kang, YK | - |
| dc.contributor.author | Pan, H | - |
| dc.contributor.author | Numata, K | - |
| dc.contributor.author | Han, G | - |
| dc.contributor.author | Balsara, B | - |
| dc.contributor.author | Zhang, Y | - |
| dc.contributor.author | Rodriguez, AM | - |
| dc.contributor.author | Zhang, Y | - |
| dc.contributor.author | Wang, Y | - |
| dc.contributor.author | Poon, RTP | - |
| dc.date.accessioned | 2016-09-20T05:22:24Z | - |
| dc.date.available | 2016-09-20T05:22:24Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Hepatology, 2016, v. 64 n. 3, p. 774–784 | - |
| dc.identifier.issn | 0270-9139 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/231336 | - |
| dc.description | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma | - |
| dc.language | eng | - |
| dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ | - |
| dc.relation.ispartof | Hepatology | - |
| dc.rights | Hepatology. Copyright © John Wiley & Sons, Inc. | - |
| dc.rights | Preprint: This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Postprint: This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Special Statement for Preprint only Before publication: 'This is a preprint of an article accepted for publication in [The Journal of Pathology] Copyright © ([year]) ([Pathological Society of Great Britain and Ireland])'. After publication: the preprint notice should be amended to follows: 'This is a preprint of an article published in [include the complete citation information for the final version of the Contribution as published in the print edition of the Journal]' For Cochrane Library/ Cochrane Database of Systematic Reviews, add statement & acknowledgement : ‘This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 20XX, Issue X. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.’ Please include reference to the Review and hyperlink to the original version using the following format e.g. Authors. Title of Review. Cochrane Database of Systematic Reviews 20XX, Issue #. Art. No.: CD00XXXX. DOI: 10.1002/14651858.CD00XXXX (insert persistent link to the article by using the URL: http://dx.doi.org/10.1002/14651858.CD00XXXX) (This statement should refer to the most recent issue of the Cochrane Database of Systematic Reviews in which the Review published.) | - |
| dc.title | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma | - |
| dc.type | Article | - |
| dc.identifier.email | Poon, RTP: poontp@hku.hk | - |
| dc.identifier.authority | Poon, RTP=rp00446 | - |
| dc.identifier.doi | 10.1002/hep.28600 | - |
| dc.identifier.scopus | eid_2-s2.0-84987909452 | - |
| dc.identifier.hkuros | 263213 | - |
| dc.identifier.volume | 64 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.spage | 774–784 | - |
| dc.identifier.epage | 774–784 | - |
| dc.identifier.isi | WOS:000383285900010 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0270-9139 | - |